By: Victoria Johnson
Published on: The emergence of targeted biologic therapies in severe asthma has fundamentally altered the treatment paradigm for a disease
United States (National)
Victoria Johnson
Geo Focus
Coverage Attributes:
Beta
Informative:
48
%
Data Driven:
40
%
Events:
3
%
Listicles:
3
%
Interviews Q&as:
1
%
Themes Covered:
Not enough data
Pitching Insights
Victoria Johnson's coverage primarily focuses on gene therapy, CRISPR technology, and cell therapy within the healthcare and pharmaceutical sectors. She heavily relies on data citations and press releases to inform her articles.
Given this emphasis, Victoria would likely be interested in receiving pitches that offer insights from experts in the fields of gene therapy, CRISPR technology, hemophilia treatment, thalassemia research or cell therapy. These experts should have a deep understanding of the latest developments in these areas and be able to provide valuable analysis based on scientific evidence.
Since she often cites data in her articles, sources with access to new study findings or clinical trial results may also capture her interest. It is important for potential contributors to ensure their information is backed by credible sources and recent studies when reaching out to her.
This information evolves through artificial intelligence and human feedback. Improve this profile .
Journalists With Similar Coverage:
Based on similarity of content.
Publications
Most recent topics
Not enough data
Publications
Most recent topics
Not enough data
Publications
Most recent topics
Not enough data
Publications
Most recent topics
Not enough data
